Form 10-Q Ocata Therapeutics, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
Ocata Therapeutics (OCAT) Reports Q3 Loss Per Share of $0.09
November 9, 2015 9:00 AM ESTOcata Therapeutics (NASDAQ: OCAT) reported Q3 EPS of ($0.09), versus ($0.13) reported last year.
For earnings history and earnings-related data on Ocata Therapeutics (OCAT) click here.
... More


